Northwest Natural (NWN) Q2 2026 Earnings Call Transcript

Northwest Natural Holding guided 2026 EPS to the upper half of $2.95–$3.15 after Q2 EPS of $0.01 (flat YoY) and YTD EPS of $2.33 vs $2.28 adjusted in 2025. The company highlighted regulatory progress—Oregon ARM settlement revenue requirement of $13M (vs $15.6M) effective Oct. 31, 2026, and Washington receiving >80% of requested increase with new rates from Aug. 1, 2026—and reiterated TX customer growth of >15% and a 260,000-meter backlog. Funding is supported by $500M–$550M 2026 capex, ~$150M net long-term debt plus $40M–$50M ATM equity, and $628M liquidity as of June 30, 2026; MX3 is a $300M, 4–5 Bcf project expected to move to notice to proceed by end-2027.

Analysis

The near-term setup is more about de-risking than acceleration. Regulatory wins in Oregon/Washington reduce the probability of a second-half earnings miss, but they also lock in a fairly slow grind of allowed-return compounding, so multiple expansion should be limited unless management proves it can convert rate relief into persistently lower financing cost and less ATM reliance. The real swing factor is whether the market starts capitalizing the Texas backlog and MX3 as a multi-year growth engine rather than treating them as future promises.

On competitive dynamics, the Texas gas platform is the cleanest second-order beneficiary: visible meter additions make it harder for regional competitors to underinvest in distribution and still keep pace on service quality, which can widen the moat if rate recovery stays timely. The more important underappreciated benefit is on the debt side: the new A- water rating and long-dated contracted storage cash flows should tighten credit spreads over time, lowering WACC and making the equity less sensitive to near-term dilution than a pure growth story would imply.

The contrarian risk is that consensus may be overvaluing the "clarity" while underweighting execution friction. The MX3 appeal, continuing ATM issuance, and a capex-heavy bridge to 2027 mean the stock can remain range-bound even if fundamentals improve; the market may wait for a hard notice-to-proceed before paying for the 5%-7% growth framework. Falsifiers: any slip in the 2027 NTP timeline, a Texas rate case settlement that lands below expected recovery, or equity issuance running above the stated 2026 pace.

Key Decisions for Investors

• Trade: modest long NWN on 1-2% pullbacks over the next 1-3 months, with a medium-term target tied to improved visibility into 2027 rate base growth; risk/reward is acceptable only if you expect the market to start valuing the MX3 option.
• Pair: long NWN / short XLU for 3-6 months if you want idiosyncratic regulatory alpha; thesis breaks if MX3 appeal delays the project past 2027 or if ATM equity issuance accelerates above the planned $40M-$50M.
• Sell into strength if NWN rerates sharply after the call: the stock likely needs an actual notice-to-proceed or a lower-cost funding update to justify a higher multiple, so upside before then is probably capped.
• Watch item: if Texas rate case output or GRIP timing slips in the next 1-2 quarters, reduce exposure; that is the cleanest indicator that the embedded 15%-20% customer growth is not translating into EPS as fast as bulls expect.
• If seeking lower-volatility exposure, prefer the debt/credit angle over equity: monitor NWN bonds or utility credit proxies rather than chasing common stock, since spread compression may arrive before a full equity rerating.